Gemfibrozil + atorvastatin may reduce cardiac risk of protease inhibitors

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 1998年 / 721卷 / 1期

关键词：

Creatine Kinase; Atorvastatin; Myopathy; Gemfibrozil; Cardiac Risk;

D O I：

10.2165/00128415-199807210-00005

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities
Henry, K
Melroe, H
Huebesch, J
Hermundson, J
Simpson, J
[J]. LANCET, 1998, 352 (9133): : 1031 - 1032
[2] Atorvastatin may reduce risk of contrast-induced AKI
Susan J. Allison
[J]. Nature Reviews Nephrology, 2013, 9 (2) : 66 - 66
[3] Protease inhibitors may increase risk of MI
[J]. Reactions Weekly, 1999, 773 (1) : 6 - 6
[4] Atorvastatin does not reduce the risk of AKI after cardiac surgery
Ellen F. Carney
[J]. Nature Reviews Nephrology, 2016, 12 (5) : 258 - 258
[5] Aromatase inhibitors may reduce endometrial cancer risk
Brower, Vicki
[J]. LANCET ONCOLOGY, 2015, 16 (04): : E164 - E164
[6] Protease inhibitors reduce mortality
不详
[J]. AIDS PATIENT CARE AND STDS, 1998, 12 (03) : 229 - 229
[7] Protease inhibitors reduce CMV
不详
[J]. AIDS PATIENT CARE AND STDS, 1999, 13 (11) : 682 - 682
[8] Mivazerol may reduce cardiac risk in vascular surgical patients
Mellor A.
[J]. Critical Care, 2 (1):
[9] Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure
Vrtovec, Bojan
Okrajsek, Renata
Golicnik, Alenka
Ferjan, Niateja
Starc, Vito
Schlegel, Todd T.
Radovancevic, Branislav
[J]. JOURNAL OF CARDIAC FAILURE, 2008, 14 (02) : 140 - 144
[10] Alpha-glucosidase inhibitors may reduce the risk of type 2 diabetes
Servey, Jessica T.
[J]. AMERICAN FAMILY PHYSICIAN, 2007, 76 (03) : 374 - 375

← 1 2 3 4 5 →